Safety profile from a Phase 1 study of external beam salvage radiotherapy in biochemical recurrence post radical prostatectomy followed by upfront adjuvant 177Lu-rhPSMA-10.1.

lutetium lu-177 tezuvotide tetraxetan (177Lu-rhPSMA-10.1) - Bracco

Krishna Kumar Chaudhary; Ashesh B. Jani; Shranav Jha; James Galt, SOB; Pretesh R. Patel; Ismaheel Lawal; David Schuster

Apr 23, 2026